Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ MYC associated targets
Phase 1 Technology Commercialization Grant: Rapid identification of in cellulo active cyclic-peptides inhibiting ‘undruggable’ MYC associated targets